Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -14.463\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) O=C(Nc1ccncc1Cl)c1ccncc1
b.) Cc1cc(CN2CCCC(CNC(=O)c3ccc(F)cc3)C2)cc(C)c1O
c.) O=C(O)[C@H](Cc1ccccc1)NC(=O)N1CCN(c2ccc(F)cc2)CC1
Answer: b. Cc1cc(CN2CCCC(CNC(=O)c3ccc(F)cc3)C2)cc(C)c1O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(CN2CCCC(CNC(=O)c3ccc(F)cc3)C2)cc(C)c1O
Cc1cc(CN2CCCC(CNC(=O)c3ccc(F)cc3)C2)cc(C)c1O
4-fluoro-N-[[1-[(4-hydroxy-3,5-dimethylphenyl)methyl]piperidin-3-yl]methyl]benzamide